Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in mice

Neoplasma

Volumn 45, Issue 1, 1998, Pages 35-39

  Golab J ^a   Zagozdzon R ^a   Stoklosa T ^a   Kaca, A ^a   Dabrowska, A ^a   Giermasz, A ^a   Feleszko, W ^a   Jakobisiak M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Granulocyte colony stimulating factor; Macrophages; Melanoma MmB16; Nitric oxide

Indexed keywords

BOVINE SERUM ALBUMIN; NITRIC OXIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; MELANOMA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031972130     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BENSINGER, W., SINGER, J., APPELBAUM, F., LILLEBY, K., LONGIN, K., ROWLEY, S., CLARKE, E., CLIFT, R., HANSEN, J., SHIELDS, T.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte colony-stimulating factor. Blood, 81, 1993, 3158-3163.
2. COLOMBO, M.P., FERRARI, G., STOPPACCIARO, A., PARENZA, M., RODOLFO, M., MAVILIO, F., PARMIANI, G.: Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med., 173, 1991, 889-897.
3. CRAWFORD, J., OZER, H., JOHNSON, D., G-CSF Study Group.: Granulocyte colony-stimulating factor: Prevention of chemotherapy induced febrile neutropenia (FN) in patients with small cell lung cancer (SCLC). Abstract. Proc. Am. Soc. Clin. Oncol., 9, 1990, 884.
4. CRAWFORD, J., OZER, H., STOLLER, R., JOHNSON, D., LYMAN, G., TABBARA, I., KRIS, M., GROUS, J., PICOZZI, V., RAUSCH, G., SMITH, R., GRADISHAR, W., YAHANDA, A., VINCENT, M., STEWART, M., GLASPY, J.: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med., 315, 1991, 164-170.
5. DEMETRI, G.D., GRIFFIN, J.D.: Granulocyte colony-stimulating factor and its receptor. Blood, 78, 1991, 2791-2808.
6. FELESZKO, W., GIERMASZ, A., GOŁAB, J., LASEK, W., KUC, K., SZPERL, M., JAKÓBISIAK, M.: Granulocyte-macrophage colony-stimulating factor accelerates growth of Lewis lung carcinoma in mice. Cancer Lett., 101, 1996, 193-197.
7. GOŁAB, J., STOKŁOSA, T., ZAGOZDŽON, R., KACA, A., KULCHITSKA, A.L., FELESZKO, W., KAWIAK, J., HOSER, G., GŁOWACKA, E., DABROWSKA, A., GIERMASZ, A., LASEK, W., JAKǑBISIAK, M.: Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in mice. Tumor Biol., 1998. (In press.)
8. KITAGAWA, S., YUO, A., SOUZA, L.M., SAITO, M., MIURA, Y., TAKAKU, F.: Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem. Biophys. Res. Commun., 144, 1987, 1143-1146.
9. LASER, W., GIERMASZ, A., KUC, K., WAŃKOWICZ, A., FELESZKO, W., GOŁAB, J., ZAGOZDZON, R., STOKŁOSA, T., JAKǑBISIAK, M.: Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor-α in mice: Correlation between in vitro and in vivo results. Int. J. Cancer, 66, 1996, 374-379.
10. LINCH, D.C., SCARFFE, H., PROCTOR, S., CHOPRA, R., TAYLOR, P.R., MORGENSTERN, G., CUNNINGHAM, D., BURNETT, A.K., CAWLEY, J.C., FRANKLIN, I.M.: Randomized vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant, 11, 1993, 307-311.
11. OHSAKA, A., SAIONJI, K., KUWAKI, T., TAKESHIMA, T., IGARI, J.: Granulocyte colony-stimulating factor modulates the surface expression of effector cell molecules on human monocytes. Br. J. Haematol., 89, 1995, 465-472.
12. PLATZER, E., WELTE, K., GABRILOVE, J., Lu, L., HARRIS, P., MERTELSMANN, R., MOORE, M.: Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J. Exp. Med., 162, 1985, 1788-1801.
13. SEIDMAN, A.D., SCHER, H.I., GABRILOVE, J.L., BAJORIN, D.F., MOTZER, R.J., O'DELL, M., CURLEY, T., DERSHAW, D.D., QUINLIVAN, S., TAO, Y.: Dose intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer. J. Clin. Oncol., 11, 1993, 408-414.
14. STOPPACCIARO, A., MELANI, C., PARENZA, M., MASTRACCHIO, A., BASSI, C., BARONI, C., PARMIANI, G., COLOMBO, M.P.: Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon γ. J. Exp. Med., 178, 1993, 151-161.
15. WILTSCHKE, C., KRAINER, M., WAGNER, A., LINKESCH, W., ZIELINSKI, C.C.: Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity. Exp. Hematol., 23, 1995, 402-406.
16. YAMAMOTO, Y., KLEIN, T.W., FRIEDMAN, H., KIMURA, S., YAMAGUCHI, H.: Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells. FEMA Immunol. Med Microbiol., 7, 1993, 15-22.
17. YONG, K.L.: Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: Comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br. J. Haematol., 94, 1996, 40-47.